Newstral
Article
timesofmalta.com on 2022-07-14 12:36
Bayer to sell testosterone drug for up to €500m
Related news
- PBayer to sell Liberty crop protection brands in Monsanto dealproducer.com
- PBayer to sell Liberty crop protection brands to get Monsanto deal passedproducer.com
- Bayer AG: Bayer drug setback adds to new CEO’s problems Financial Times
- Bayer to sell assets to BASF, 300 in N.C. impactedbizjournals.com
- Bayer to sell seed assets to ease antitrust concerns: Reportbizjournals.com
- Bayer to sell $9B in agriculture assets to buy Monsantobizjournals.com
- Bayer to sell assets to BASF, 300 in RTP impactedbizjournals.com
- FBayer to sell animal health business to Elanco for $7.6bnft.com
- Bayer Plans to Sell Brands Including Coppertone and Dr. Schollwsj.com
- Bayer agrees to sell its Dr. Scholl's businessbizjournals.com
- In court after trying to sell drug to policemantimesofmalta.com
- Bayer using AI to improve disease diagnosis, drug designreviewtimes.com
- Bayer to sell more units to BASF to enable Monsanto dealnwaonline.com
- FBayer to sell Dr Scholl’s to private equity in bid to focus on coreft.com
- Bayer to Sell More Assets to Win Approval for Monsanto Dealwsj.com
- Bayer returns to profit despite US lawsuitstimesofmalta.com
- Monsanto deal prompts Bayer to sell pieces of unit with big KC presencebizjournals.com
- Bayer CEO plans to sell animal health operations by year endbizjournals.com
- Covestro to sell off part of former Bayer campus in Robinsonpost-gazette.com